[ORGANIZATION]
Humira
Featured in 2 tracked stories · first seen
Situations
AbbVie immunology pipeline and strategic transition
2 clusters · 4 sources · last updated
Latest: AbbVie completes $10.9 billion acquisition of Apogee Therapeutics
AbbVie is undergoing a strategic transition to mitigate the impact of biosimilar competition on its blockbuster drug, Humira. Following a decline in Humira sales to $6.4 billion in 2025, the company has relied on the gro